Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Cell & Gene Therapy International
September 22-25, 2026 as part of Biotech Week Boston
Hynes Convention CenterBoston, MA
Book Now
Menu
Book
Key Sessions
Hari Pujar
Keynote: In Vivo CAR-T Therapies Product Development and Clinical Advances
Tessera Therapeutics
Arvind Natarajan
Keynote Panel Discussion: Scaling Cell Therapies- Lessons from Pioneers for Smarter, Faster, and More Affordable Ex Vivo Cell Therapy Manufacturing
Iovance Biotherapeutics
Craig Malzahn
Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing
Regenxbio
keyboard_arrow_right

Thursday 24th September - Conference Day Two - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Thursday 24th September - Conference Day Two - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
8:50am - 9:00am
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
  • Nicola Ambler - Co-Founder, CGT Circle
9:00am - 9:30am
Keynote: In Vivo CAR-T Therapies Product Development and Clinical Advances
  • Hari Pujar - Chief Operating Officer, Tessera Therapeutics
9:30am - 10:00am
Regulatory Considerations for In Vivo CAR-T
  • Christopher Bravery - Consulting Regulatory Scientist, Advbiols
Showing 1 of 1 Streams
11:30am - 11:45am
High-Throughput Signal Peptide Engineering for Cell and Gene Therapy: From Single Chains to Multichain Biologics
  • Tero-Pekka Alastalo - CEO, Avenue Biosciences
11:45am - 12:30pm
Designing for the Unknown: How Do You Plan CGT Manufacturing Facilities When the Patient Count is a Moving Target?
  • Samir Gondalia - Director, Business Development and Marketing, Hart Companies
  • Kristi Ballard - Senior Director, Cell Therapy Manufacturing, Bristol Myers Squibb
  • Adam Bartley - Chief Operating Officer, Chrysalis
  • Kelly Kral - VP of CMC Strategy & Ops, Genetix Biotherapeutics
12:30pm - 1:00pm
Streamlining the Critical Path for AAV Gene Therapy Development: Platform Strategies to Accelerate Clinical Readiness
  • Philip Wills - Chief Commercial Officer, Catalent
Showing 1 of 1 Streams
2:40pm - 2:45pm
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
2:45pm - 3:15pm
Leveraging Platform-Based, Multi-Attribute LC Assays to Characterize Multi-components Prime Editing (PE) RNA-LNP
  • Minjia Wang - Analytical Development Scientist II, Prime Medicine
3:15pm - 3:45pm
Unlocking the Promise of In Vivo CAR-T: CMC Strategies for Scalable, Rapid, and Accessible Cell Therapies
  • Huiyi Zhu - Head of US Project Management, ProBio
Showing 1 of 1 Streams
4:30pm - 5:30pm
Panel Discussion: Starting with the End in Mind: Designing Smart and Phase Appropriate Manufacturing for Successful Cell and Gene Therapy Development
  • Khandan Baradaran - Principal, Mill Creek Consulting LLC
  • Shankar Swaminathan, PhD - Team Lead, Drug Product Development, CMC-Tech Ops, Astellas Institute for Regenerative Medicine
  • Amy Shaw - Senior Director, Process Development, Genetix Biotherapeutics
  • James Warren - SVP, Global CMC Development, Ultragenyx
  • Nathan Moore - Technology and Digital Innovation Leader | Cell Therapy Manufacturing, Independent Consultant
Wednesday 23rd September - Conference Day One
NextFriday 25th September - Conference Day Three
Filter
Streams
Clear
Choose Day